Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,574 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00547157 | Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 152 | AmgenINDUSTRY | 0 | Mar 15, 2017 | clinicaltrials |
| NCT00729157 | Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2017 | clinicaltrials |
| NCT01534897 | Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00482872 | Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | completed | — | 400 | Vanderbilt University Medical CenterOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00896948 | Study of Proteins in Head and Neck Cancer Cells | completed | — | — | Vanderbilt University Medical CenterOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00897988 | DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx | completed | — | 40 | Vanderbilt University Medical CenterOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00899769 | Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers | completed | — | 100 | Vanderbilt University Medical CenterOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00953849 | Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity | completed | Phase 1 / Phase 2 | 21 | VA Office of Research and DevelopmentFED | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00095628 | SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2017 | clinicaltrials |
| NCT01342978 | Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time(HOTSPOT) | completed | — | 242 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Mar 1, 2017 | clinicaltrials |
| NCT00580138 | Real-Time Internet Evaluation of Swallowing | completed | — | 30 | University of ArkansasOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT00057785 | Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer | completed | Phase 2 | 68 | Radiation Therapy Oncology GroupNETWORK | 1 | Feb 17, 2017 | clinicaltrials |
| NCT00118248 | Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02323672 | Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions | completed | — | 45 | Cairo UniversityOTHER | 0 | Feb 10, 2017 | clinicaltrials |
| NCT00848042 | Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck | completed | N/A | 11 | Nanospectra Biosciences, Inc.INDUSTRY | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02104323 | Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors(Endostatin) | completed | Phase 2 | 20 | Beijing Tiantan HospitalOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT00453336 | Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract | completed | Phase 2 | 45 | University of MiamiOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT00516087 | LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)(NATELLA) | completed | Phase 1 | 23 | Baylor College of MedicineOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00270790 | EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) | completed | Phase 2 | 21 | Mohan SuntharalingamOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT01604759 | Polarized Reflectance Spectroscopy for Oral Lesions(PolProbe) | completed | Phase 1 | 40 | British Columbia Cancer AgencyOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT00358956 | A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer | completed | Phase 2 | 19 | Genzyme, a Sanofi CompanyINDUSTRY | 8 | Jan 30, 2017 | clinicaltrials |
| NCT00559949 | Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 2 | Jan 30, 2017 | clinicaltrials |
| NCT01040832 | EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 107 | EMD SeronoINDUSTRY | 8 | Jan 30, 2017 | clinicaltrials |
| NCT01347281 | PET With [18F]HX4 in Head and Neck Cancer | completed | N/A | 23 | Maastricht Radiation OncologyOTHER | 1 | Jan 30, 2017 | clinicaltrials |
| NCT01903967 | Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)(PITUIGENE) | completed | — | 213 | Hospices Civils de LyonOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT03026361 | Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity | completed | — | 71 | University of ZagrebOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00003200 | Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck | completed | Phase 1 | 22 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2017 | clinicaltrials |
| NCT00003744 | Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | completed | Phase 2 | 16 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2017 | clinicaltrials |
| NCT01370070 | MK-2206 in Recurrent Nasopharyngeal Carcinoma(MC1079) | completed | Phase 2 | 12 | Chinese University of Hong KongOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT03015077 | Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy | completed | N/A | 59 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT00901680 | Creation of the BioBank, Early Detection and Discovery Biomarkers | completed | — | 3,028 | Corewell Health EastOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT03013699 | Diet Intervention, Head and Neck Cancer, Feasibility | completed | N/A | 23 | University of Alabama at BirminghamOTHER | 0 | Jan 6, 2017 | clinicaltrials |
| NCT00002727 | Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord | completed | Phase 3 | 250 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 4, 2017 | clinicaltrials |
| NCT00095927 | Randomized Amifostine For SCCHN | completed | Phase 2 | 58 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT01553851 | GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer | completed | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Dec 26, 2016 | clinicaltrials |
| NCT00131638 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | completed | Phase 3 | 241 | AmgenINDUSTRY | 0 | Dec 16, 2016 | clinicaltrials |
| NCT00705640 | Vaccine Therapy in Treating Patients With Advanced Melanoma(Mel48) | completed | Phase 1 | 45 | Craig L Slingluff, JrOTHER | 1 | Dec 16, 2016 | clinicaltrials |
| NCT00002533 | Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer | completed | Phase 2 / Phase 3 | — | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT00003582 | Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer | completed | Phase 1 / Phase 2 | 36 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT00448552 | Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer | completed | Phase 2 | 30 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT00042926 | Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer | completed | N/A | 161 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT01025518 | DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients | completed | N/A | 30 | Danish Head and Neck Cancer GroupNETWORK | 1 | Nov 29, 2016 | clinicaltrials |
| NCT01083550 | Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | completed | Phase 2 / Phase 3 | 74 | University Health Network, TorontoOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT01509430 | DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC | completed | N/A | 41 | Danish Head and Neck Cancer GroupNETWORK | 1 | Nov 29, 2016 | clinicaltrials |
| NCT00442520 | Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy | completed | — | 70 | University of Kansas Medical CenterOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT00496652 | DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC | completed | Phase 3 | 619 | Danish Head and Neck Cancer GroupNETWORK | 1 | Nov 25, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Mar 15, 2017source: clinicaltrials